BRIEF published on 06/14/2024 at 11:53, 1 year 9 months ago Publication of the annual report of Novacyt SA Technologies Annual Report 2023 Novacyt Molecular Diagnosis Integrated Services
BRIEF published on 06/14/2024 at 11:51, 1 year 9 months ago Novacyt Publishes Annual Report for 2023 Financial Results Annual Report Molecular Diagnostics Novacyt
PRESS RELEASE published on 06/14/2024 at 11:46, 1 year 9 months ago Publication of Annual Report Novacyt S.A. announces the publication of its Annual Report for the year ended 31 December 2023. The report is available on the company's website Annual Report Euronext Growth Molecular Diagnostics Novacyt S.A. Integrated Technologies
BRIEF published on 06/04/2024 at 15:16, 1 year 9 months ago Novacyt General Meeting: Shareholder Vote Approaching Shareholders General Assembly Quorum Vote Novacyt
BRIEF published on 06/04/2024 at 15:15, 1 year 9 months ago Novacyt S.A. Announces AGM Voting Procedures Shareholders AGM Voting Molecular Diagnostics Novacyt
PRESS RELEASE published on 06/04/2024 at 15:10, 1 year 9 months ago AGM voting Novacyt S.A. announces AGM voting to be held online on 26 June 2024. Shareholders can vote in advance and access meeting details at www.novacyt.com/investors Shareholders AGM Voting Novacyt S.A. Online Meeting
BRIEF published on 06/03/2024 at 15:52, 1 year 9 months ago Novacyt: Monthly review of the liquidity contract and voting rights Liquidity Contract Actions INVEST SECURITIES Right To Vote Novacyt
BRIEF published on 05/20/2024 at 10:56, 1 year 9 months ago Novacyt announces the publication of its financial results and convenes its Annual General Meeting Financial Results Investors Webinar General Assembly Novacyt
BRIEF published on 05/20/2024 at 10:54, 1 year 9 months ago Novacyt Announces Financial Results and Annual General Meeting Financial Results AGM Molecular Diagnostics Investor Webinar Novacyt
PRESS RELEASE published on 05/20/2024 at 10:49, 1 year 9 months ago Notice of Results and Annual General Meeting Novacyt S.A. will report its audited financial results for the year ended 31 December 2023 on 30 May 2024 and hold its Annual General Meeting on 26 June 2024. An investor webinar is scheduled for 30 May 2024 Financial Results Annual General Meeting Molecular Diagnostics Investor Webinar Novacyt S.A.
Published on 03/19/2026 at 06:35, 19 minutes ago Golden Lake Announces Securityholder Approval of Arrangement with McEwen Inc.
Published on 03/19/2026 at 01:05, 5 hours 49 minutes ago Prospect Ridge Announces Closing of Flow-Through Share Private Placement
Published on 03/18/2026 at 23:45, 7 hours 9 minutes ago Orogen Royalties Announces Private Placement Update
Published on 03/18/2026 at 21:00, 9 hours 54 minutes ago PLDT's Smart Selects Amdocs to Transform Retail Operations with AI-Powered Store Genie
Published on 03/18/2026 at 19:05, 11 hours 49 minutes ago Deposit Modeling at Thor Shows that the Proven Thor Epithermal Deposit is Flanked on Both Sides by a Much Larger Deposit
Published on 03/19/2026 at 06:30, 23 minutes ago Helvetica Swiss Commercial Fund confirms strong earnings quality and achieves attractive investment and dividend returns
Published on 03/19/2026 at 06:30, 23 minutes ago Helvetica Swiss Living Fund concludes its successful strategic optimization phase with a strong annual result for 2025 and focuses on further value creation in the portfolio
Published on 03/19/2026 at 06:30, 24 minutes ago Formycon secures license date for aflibercept 2 mg biosimilar FYB203 in Europe and further territories following settlement with Regeneron and Bayer
Published on 03/19/2026 at 06:05, 48 minutes ago Global terrorism falls to a decade low but Western fatalities surge
Published on 03/18/2026 at 19:41, 11 hours 12 minutes ago Covivio - Conditions of availability of the 2025 Universal Registration Document
Published on 03/18/2026 at 18:00, 12 hours 54 minutes ago Deezer achieves profitability in FY25 as strategy delivers tangible results
Published on 03/18/2026 at 17:45, 13 hours 9 minutes ago Infotel : 2025 full-year results. Launch of a new Infotel 2030 strategic plan. Revenue target of €500 million by 2030.
